Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-EN Version v5-EN
Language English English
Date Updated 2019-07-31 2019-06-18
Drug Identification Number 02462680 02462680
Brand name TEPADINA TEPADINA
Common or Proper name Thiotepa for Injection Thiotepa for Injection
Company Name ADIENNE SA ADIENNE SA
Ingredients THIOTEPA THIOTEPA
Strength(s) 15MG 15MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 vial 1 vial
ATC code L01AC L01AC
ATC description
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-06-17
Actual start date 2019-07-12
Estimated end date 2019-07-30
Actual end date 2019-07-30
Shortage status Resolved Actual shortage
Company comments TEPADINA 100mg (DIN 02462702) is available. For more information please contact Methapharm at 1-800-287-7686, sales@methapharm.com, or fax 519-751-9149 Please also contact ADIENNE at med-info@adienne.com for further information TEPADINA 100mg (DIN 02462702) is available. For more information please contact Methapharm at 1-800-287-7686, sales@methapharm.com, or fax 519-751-9149 Please also contact ADIENNE at med-info@adienne.com for further information
Health Canada comments